CIBC Private Wealth Group LLC Buys 10,923 Shares of Rentokil Initial plc (NYSE:RTO)

CIBC Private Wealth Group LLC grew its stake in shares of Rentokil Initial plc (NYSE:RTO) by 10.1% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 118,689 shares of the company’s stock after purchasing an additional 10,923 shares during the quarter. CIBC Private Wealth Group LLC’s holdings in Rentokil Initial were worth $2,862,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Verition Fund Management LLC bought a new stake in Rentokil Initial during the third quarter worth $805,000. HighTower Advisors LLC raised its holdings in shares of Rentokil Initial by 36.8% in the 3rd quarter. HighTower Advisors LLC now owns 88,747 shares of the company’s stock valued at $2,205,000 after purchasing an additional 23,892 shares during the period. Janus Henderson Group PLC grew its holdings in Rentokil Initial by 3.8% during the third quarter. Janus Henderson Group PLC now owns 16,990,179 shares of the company’s stock worth $423,573,000 after purchasing an additional 617,227 shares during the period. Michelson Medical Research Foundation Inc. bought a new position in Rentokil Initial during the third quarter worth about $4,487,000. Finally, XTX Topco Ltd raised its stake in Rentokil Initial by 22.5% in the third quarter. XTX Topco Ltd now owns 20,768 shares of the company’s stock valued at $518,000 after buying an additional 3,808 shares during the period. Institutional investors own 9.91% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Citigroup raised shares of Rentokil Initial to a “strong-buy” rating in a research report on Friday, December 13th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Rentokil Initial in a research note on Friday, March 7th. Four investment analysts have rated the stock with a hold rating, one has given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Rentokil Initial currently has an average rating of “Moderate Buy”.

Rentokil Initial Price Performance

RTO stock opened at $23.18 on Thursday. The stock has a market cap of $11.70 billion, a price-to-earnings ratio of 15.35, a P/E/G ratio of 7.95 and a beta of 1.14. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.04 and a quick ratio of 0.96. The company has a 50 day simple moving average of $24.16 and a 200 day simple moving average of $24.77. Rentokil Initial plc has a 1 year low of $20.60 and a 1 year high of $34.07.

Rentokil Initial Dividend Announcement

The business also recently declared a semi-annual dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 4th will be issued a dividend of $0.3825 per share. The ex-dividend date of this dividend is Friday, April 4th. This represents a dividend yield of 2.4%. Rentokil Initial’s dividend payout ratio (DPR) is presently 43.71%.

Rentokil Initial Profile

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.